Rituximab therapy for adult refractory systemic lupus erythematosus with neurological and/or psychiatric presentations: a PRISMA-compliant meta-analysis.
Mehran Asad AyoubiMaryam MoghaddasiMehdi AlooshPublished in: Current rheumatology reviews (2024)
RTX therapy had good effectiveness. The pooled evidence for safety outcomes was limited and of low certainty.
Keyphrases
- systematic review
- systemic lupus erythematosus
- meta analyses
- randomized controlled trial
- disease activity
- mental health
- diffuse large b cell lymphoma
- hodgkin lymphoma
- chronic lymphocytic leukemia
- stem cells
- rheumatoid arthritis
- case control
- bone marrow
- metabolic syndrome
- young adults
- childhood cancer
- cerebral ischemia
- cell therapy
- glycemic control
- subarachnoid hemorrhage